Unlock complex cell-based binding and avidity dynamics
Thursday, February 27 at 15:00 GMT / 16:00 CET / 10:00 EST / 7:00 PST
Join Dr. Nichole Cerutti, Director of Biophysics at RoukenBio, and Dr. Vivien Hafner, Head of Scientific Communication and Marketing at Bruker Biosensors to unlock the power within single-cell interaction cytometry, and its key role in the development of therapeutics.
These industry experts will showcase the innovative IndEx-2 system created to enable control of titratable protein expression levels. Learn how the combination of the IndEx-2 system and single-cell interaction cytometry can enhance the understanding of therapeutic interactions and efficacy at the cellular level, in the context of different levels of target protein expression.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
Speakers
Who should attend?
- Translational researchers working in drug discovery and development who are interested in biotherapeutic molecule development, particularly in the areas of oncology, immuno-oncology, auto-immunity, allergy and inflammatory diseases
What will this webinar cover?
- Understand how different levels of target expression can affect the key characteristics of targeted therapeutics with the IndEx-2 platform
- Discover single-cell interaction cytometry and how it can be used to characterize the kinetics of therapeutic molecules in a more physiologically relevant setting e.g. when binding to their targets on the cell surface
- Explore how the implementation of inducible cell lines with this technology can aid understanding of the binding capabilities of targeted therapeutics
- Learn how target density can influence the kinetics and avidity of molecule binding